Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 252, pseudogene (ZNF252P) is a non-functional copy of the ZNF252 gene, classified as a pseudogene and located on chromosome 19. Pseudogenes are remnants of once-functional genes and, by definition, do not code for an active protein product[2]. Zinc finger proteins are generally DNA-binding proteins involved in transcriptional regulation, but pseudogenes like ZNF252P do not perform these biological roles and are not considered therapeutic targets[2][1]. Essential context: ZNF252P is a pseudogene, not a protein-coding gene or a functional receptor, enzyme, transporter, or therapeutic target[2]. Pseudogenes are often remnants of formerly functional genes and generally do not produce functional proteins relevant for drug targeting or disease mechanism studies[2]. While zinc finger proteins have important regulatory and transcription factor roles[1][5][3], ZNF252P itself does not have known biological or disease-related functions due to its non-functionality[2]. Summary of special considerations: The target is not druggable or therapeutically relevant. No documented biological functions, disease associations, drugs, or mechanisms of action exist for ZNF252P. This entry is marked as 'is_incorrect: true' because ZNF252P is not a true therapeutic target, is non-functional, and likely was included due to mistaken equivalence with functional zinc finger proteins. Its correct molecular classification is 'Other' rather than, for example, 'Transcription factor' or 'Enzyme', because a pseudogene does not have a protein product[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 252, pseudogene (ZNF252P).